NDC 0069-1111 - ABRILADA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-1111
- Package NDCs from labels
- 0069-1111-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ABRILADA - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| ABRILADA - A-S Medication Solutions | A-S Medication Solutions | 2026-06-18 | HUMAN PRESCRIPTION DRUG LABEL |
| ABRILADA | Pfizer Laboratories Div Pfizer Inc | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Belgium NV | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
| ABRILADA | Pfizer Laboratories Div Pfizer Inc | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Belgium NV | 2025-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| BeneFIX - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Wyeth Farma SA | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Wyeth Farma SA | 2025-02-24 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-1111-01 | BeneFIX | 1 mL in 1 PACKET | SWAB | 2 mL | 70 mL in 100mL | 45 |
| 0069-1111-01 | BeneFIX | 1 mL in 1 PACKET | SWAB | 2 mL | 70 mL in 100mL | 45 |
| 0069-1111-01 | BeneFIX | 1 mL in 1 PACKET | SWAB | 2 mL | 70 mL in 100mL | 45 |
| 0069-1111-01 | BeneFIX | 1 mL in 1 PACKET | SWAB | 2 mL | 70 mL in 100mL | 45 |
| 0069-1111-01 | BeneFIX | 1 mL in 1 PACKET | SWAB | 2 mL | 70 mL in 100mL | 45 |
| 0069-1111-01 | ABRILADA | 1 mL in 1 PACKET | SWAB | 1 mL | 70 mL in 100mL | 8 |
| 0069-1111-01 | ABRILADA | 1 mL in 1 PACKET | SWAB | 1 mL | 70 mL in 100mL | 8 |
| 0069-1111-01 | ABRILADA | 1 mL in 1 PACKET | SWAB | 1 mL | 70 mL in 100mL | 8 |
| 0069-1111-01 | ABRILADA | 1 mL in 1 PACKET | SWAB | 1 mL | 70 mL in 100mL | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0069-1111 | BENEFIX (COAGULATION FACTOR IX (RECOMBINANT)) KIT [WYETH BIOPHARMA DIVISION OF WYETH PHARMACEUTICALS LLC] | 45 | Unmatched | 20250227_85faa5bc-cee5-4ef1-8d80-bdbcb7eba1e4.zip |
| 0069-1111 | ABRILADA (ADALIMUMAB-AFZB) KIT ABRILADA (ADALIMUMAB-AFZB) SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 9 | Unmatched | 20250119_81a33cfa-262f-4432-a05d-7dd260928437.zip |
| 0069-1111 | ABRILADA (ADALIMUMAB-AFZB) KIT ABRILADA (ADALIMUMAB-AFZB) INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 5 | Unmatched | 20250116_5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Aging Eye Formula | CINERARIA MARITIMA, EYE (SUIS), CALCAREA FLUORICA, CAUSTICUM, PHOSPHORUS, SILICEA, ZINCUM METALLICUM, GERMANIUM METALLICUM, NATRUM MURIATICUM | Nutritional Specialties, Inc. | d5b44f79-5299-4b31-ba45-0e511cdbe17c | 2026-08-24 | Warnings | 451W47IQ8X |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-08-20 | Warnings | 6OZP39ZG8H |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | YYBA CORP | 597f3347-647c-3545-e063-6294a90abab2 | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Sinusforce-HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA | BioActive Nutritional, Inc. | 53c96680-210b-4426-8b41-3b9a882848dd | 2026-08-20 | Warnings | 451W47IQ8X |
| CVS Saline | NASAL | CVS PHARMACY | f02c41b0-c78e-41cd-aa4a-2756bbe92087 | 2026-08-19 | Warnings | 451W47IQ8X |
| TrophAmine | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE | B. Braun Medical Inc. | cb6d23ff-3ec5-445a-acbe-f88fd57949bf | 2026-08-19 | Warnings, Adverse reactions | 4QD397987E TE7660XO1C AE28F7PNPL |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| inControl alcohol | ISOPROPYL ALCOHOL | H-E-B | 45dfbd7a-0ae1-4146-9527-5483c884e636 | 2026-08-18 | Warnings | 797544 ND2M416302 |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| ZYMFENTRA | INFLIXIMAB-DYYB | CELLTRION USA Inc. | 93a193ab-9f96-4da6-aa7c-31212e81879a | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | 797544 |
| 70% Isopropyl Rubbing Alcohol | ISOPROPYL RUBBING ALCOHOL | The Kroger Co. | b127bba1-ce0b-4142-8b7d-f12f062b0938 | 2026-08-17 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | The Kroger Co. | cd3f8779-9e57-4b23-a029-7424d4d4ab2a | 2026-08-17 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | The Kroger Co. | ca6c7f8a-d41a-4d77-817c-3dbdc40f890e | 2026-08-17 | Warnings, Adverse reactions | ND2M416302 |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM173 DROPS | ECHINACEA, EUPHRASIA, NATRUM MUR, RHUS TOX, SILICEA, SULPHUR, URTICA UREN | BM Private Limited | 59036ca4-e7bb-bbe7-e063-6394a90a410a | 2026-08-14 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.